(Q50050270)

English

Efficacy and safety of Abraxane in treatment of progressive and recurrent non-small cell lung cancer patients: A retrospective clinical study.

scientific article published in November 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/28920278

Efficacy and safety of Abraxane in treatment of progressive and recurrent non-small cell lung cancer patients: A retrospective clinical study. (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/28920278

author name string

Dong-Mei Yuan

1

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/28920278

Yan-Ling Lv

2

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/28920278

Yan-Wen Yao

3

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/28920278

Xiao-Hui Miao

4

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/28920278

Qian Wang

5

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/28920278

Xin-Wu Xiao

6

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/28920278

Jie Yin

7

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/28920278

Yi Shi

8

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/28920278

Mei-Qi Shi

9

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/28920278

Xiu-Wei Zhang

10

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/28920278

Yong Song

11

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/28920278

publication date

1 November 2012

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/28920278

Thoracic Cancer

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/28920278

3

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/28920278

4

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/28920278

341-347

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/28920278

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1111%2FJ.1759-7714.2012.00113.X

21 January 2018

Chemotherapy for advanced non-small-cell lung cancer: how much benefit is enough?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1759-7714.2012.00113.X

21 January 2018

Management of patients with advanced non-small cell lung cancer: current and emerging options

1 reference

https://api.crossref.org/works/10.1111%2FJ.1759-7714.2012.00113.X

21 January 2018

Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1759-7714.2012.00113.X

21 January 2018

Taxol: a novel investigational antimicrotubule agent

1 reference

https://api.crossref.org/works/10.1111%2FJ.1759-7714.2012.00113.X

21 January 2018

Randomized trial of paclitaxel plus supportive care versus supportive care for patients with advanced non-small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1759-7714.2012.00113.X

21 January 2018

A multicenter, randomized, phase III study of docetaxel plus best supportive care versus best supportive care in chemotherapy-naive patients with metastatic or non-resectable localized non-small cell lung cancer (NSCLC).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1759-7714.2012.00113.X

21 January 2018

Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1759-7714.2012.00113.X

21 January 2018

Hypersensitivity reactions from taxol

1 reference

https://api.crossref.org/works/10.1111%2FJ.1759-7714.2012.00113.X

21 January 2018

Phase I and pharmacokinetic study of BMS-184476, a taxane with greater potency and solubility than paclitaxel

1 reference

https://api.crossref.org/works/10.1111%2FJ.1759-7714.2012.00113.X

21 January 2018

Comparative preclinical and clinical pharmacokinetics of a cremophor-free, nanoparticle albumin-bound paclitaxel (ABI-007) and paclitaxel formulated in Cremophor (Taxol).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1759-7714.2012.00113.X

21 January 2018

Phase I/II trial of weekly intravenous 130-nm albumin-bound paclitaxel as initial chemotherapy in patients with stage IV non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1759-7714.2012.00113.X

21 January 2018

Phase II trial of nanoparticle albumin-bound paclitaxel, carboplatin, and bevacizumab in first-line patients with advanced nonsquamous non-small cell lung cancer.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1759-7714.2012.00113.X

21 January 2018

Abraxane, a novel Cremophor-free, albumin-bound particle form of paclitaxel for the treatment of advanced non-small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1759-7714.2012.00113.X

21 January 2018

Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1759-7714.2012.00113.X

21 January 2018

A phase II study of pemetrexed and carboplatin as a salvage therapy for platinum-pretreated patients with non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1759-7714.2012.00113.X

21 January 2018

Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trial.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1759-7714.2012.00113.X

21 January 2018

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

1 reference

https://api.crossref.org/works/10.1111%2FJ.1759-7714.2012.00113.X

21 January 2018

The meaning and use of the area under a receiver operating characteristic (ROC) curve

1 reference

https://api.crossref.org/works/10.1111%2FJ.1759-7714.2012.00113.X

21 January 2018

First-generation epidermal growth factor receptor inhibitors in non-small cell lung cancer: clinical impact of the epidermal growth factor receptor fluorescence in situ hybridization assay

1 reference

https://api.crossref.org/works/10.1111%2FJ.1759-7714.2012.00113.X

21 January 2018

Phase I and pharmacokinetic study of ABI-007, albumin-bound paclitaxel, administered every 3 weeks in Japanese patients with solid tumors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1759-7714.2012.00113.X

21 January 2018

Phase III Trial of Nanoparticle Albumin-Bound Paclitaxel Compared With Polyethylated Castor Oil–Based Paclitaxel in Women With Breast Cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1759-7714.2012.00113.X

21 January 2018

Pharmacology and toxicology of Cremophor EL diluent

1 reference

https://api.crossref.org/works/10.1111%2FJ.1759-7714.2012.00113.X

21 January 2018

Identifiers

10.1111/J.1759-7714.2012.00113.X

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/28920278

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 February 2018

http://europepmc.org/abstract/MED/28920278

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50050270&oldid=2183348761"